Our News

[et_pb_section fb_built=”1″ _builder_version=”3.22.3″ custom_margin=”-50px|||” locked=”off”][et_pb_row module_class=” et_pb_row_fullwidth” _builder_version=”3.26.3″ width=”89%” width_tablet=”80%” width_phone=”” width_last_edited=”on|desktop” max_width=”89%” max_width_tablet=”80%” max_width_phone=”” max_width_last_edited=”on|desktop” custom_margin=”|auto||auto|false|false” make_fullwidth=”on”][et_pb_column type=”4_4″ _builder_version=”3.25″ custom_padding=”|||” custom_padding__hover=”|||”][et_pb_text admin_label=”La sérialisation est en marche” _builder_version=”4.0.5″ text_font=”Oxygen||||||||” text_text_color=”#42bcff” header_2_font=”Oxygen||||||||” header_2_text_align=”center” header_2_text_color=”#42bcff” header_2_font_size=”35px” text_orientation=”center” hover_enabled=”0″]

SYNERLAB, YOUR WORLDWIDE PARTNER FOR CONTRACT DEVELOPMENT & MANUFACTURING SERVICES

 

[/et_pb_text][et_pb_image src=”http://www.synerlab.com/wp-synerlab/wp-content/uploads/2020/01/SYN_APA4_THE_PHARMA_POST_FB_HD_G-pdf.jpg” align=”center” _builder_version=”4.0.5″ width=”35%” max_width=”35%” module_alignment=”center” hover_enabled=”0″ url=”https://www.synerlab.com/wp-synerlab/wp-content/uploads/2020/01/SYN_APA4_THE_PHARMA_POST_FB_HD_G.pdf” url_new_window=”on”][/et_pb_image][et_pb_divider _builder_version=”4.0.5″ custom_margin=”50px||||false|false”][/et_pb_divider][/et_pb_column][/et_pb_row][/et_pb_section][et_pb_section fb_built=”1″ _builder_version=”3.22.3″ custom_margin=”-50px|||” locked=”off”][et_pb_row module_class=” et_pb_row_fullwidth” _builder_version=”3.26.3″ width=”89%” width_tablet=”80%” width_phone=”” width_last_edited=”on|desktop” max_width=”89%” max_width_tablet=”80%” max_width_phone=”” max_width_last_edited=”on|desktop” custom_margin=”|auto||auto|false|false” make_fullwidth=”on”][et_pb_column type=”4_4″ _builder_version=”3.25″ custom_padding=”|||” custom_padding__hover=”|||”][et_pb_video src=”https://youtu.be/mm4IzcHX8Ak” _builder_version=”3.27.4″][/et_pb_video][/et_pb_column][/et_pb_row][/et_pb_section][et_pb_section fb_built=”1″ _builder_version=”3.22.3″ custom_margin=”-50px|||” locked=”off”][et_pb_row module_class=” et_pb_row_fullwidth” _builder_version=”3.26.3″ width=”89%” width_tablet=”80%” width_phone=”” width_last_edited=”on|desktop” max_width=”89%” max_width_tablet=”80%” max_width_phone=”” max_width_last_edited=”on|desktop” custom_margin=”|auto||auto|false|false” make_fullwidth=”on”][et_pb_column type=”4_4″ _builder_version=”3.25″ custom_padding=”|||” custom_padding__hover=”|||”][et_pb_text admin_label=”La sérialisation est en marche” _builder_version=”3.27.4″ text_font=”Oxygen||||||||” text_text_color=”#42bcff” header_2_font=”Oxygen||||||||” header_2_text_align=”center” header_2_text_color=”#42bcff” header_2_font_size=”35px” text_orientation=”center”]

 

WORKSHOP SESSION

« LEADING THE GAME WITH SYNERLAB »

 

[/et_pb_text][et_pb_image src=”http://www.synerlab.com/wp-synerlab/wp-content/uploads/2019/07/Seiten-aus-1890_programme_seminaire-page-980.jpg” url=”http://www.synerlab.com/wp-synerlab/wp-content/uploads/2019/07/1890_programme_seminaire_vect-ss-trait-coupe-planche-1.pdf” url_new_window=”on” _builder_version=”3.26.3″ width=”60%” max_width=”60%” module_alignment=”center”][/et_pb_image][et_pb_divider _builder_version=”3.26.3″ custom_margin=”50px||||false|false” custom_padding=”||||true|false”][/et_pb_divider][/et_pb_column][/et_pb_row][/et_pb_section][et_pb_section fb_built=”1″ _builder_version=”3.22.3″ custom_margin=”-50px|||” locked=”off”][et_pb_row module_class=” et_pb_row_fullwidth” _builder_version=”3.25″ width=”89%” width_tablet=”80%” width_phone=”” width_last_edited=”on|desktop” max_width=”89%” max_width_tablet=”80%” max_width_phone=”” max_width_last_edited=”on|desktop” make_fullwidth=”on”][et_pb_column type=”4_4″ _builder_version=”3.25″ custom_padding=”|||” custom_padding__hover=”|||”][et_pb_text admin_label=”LYOFAL given the go-ahead to produce cytotoxic medicinal products” _builder_version=”3.27.4″ text_font=”Oxygen||||||||” text_text_color=”#42bcff” header_2_font=”Oxygen||||||||” header_2_text_align=”center” header_2_text_color=”#42bcff” header_2_font_size=”35px” text_orientation=”center” animation_style=”zoom”]

Groupe SYNERLAB

 

A MAJOR PLAYER IN PHARMACEUTICAL DEVELOPMENT

 

Enjoy your reading!

[/et_pb_text][et_pb_divider _builder_version=”3.25.3″ custom_margin=”-60px|||” custom_padding=”40px||40px||true”][/et_pb_divider][/et_pb_column][/et_pb_row][/et_pb_section][et_pb_section fb_built=”1″ _builder_version=”3.25.3″ custom_margin=”-80px|||” locked=”off”][et_pb_row module_class=” et_pb_row_fullwidth” _builder_version=”3.25″ width=”89%” width_tablet=”80%” width_phone=”” width_last_edited=”on|desktop” max_width=”89%” max_width_tablet=”80%” max_width_phone=”” max_width_last_edited=”on|desktop” make_fullwidth=”on” locked=”off”][et_pb_column type=”4_4″ _builder_version=”3.25″ custom_padding=”|||” custom_padding__hover=”|||”][et_pb_text admin_label=”LYOFAL autorisée à produire des médicaments cytotoxiques” _builder_version=”3.27.4″ text_font=”Oxygen||||||||” text_text_color=”#42bcff” header_2_font=”Oxygen||||||||” header_2_text_align=”center” header_2_text_color=”#42bcff” header_2_font_size=”35px” text_orientation=”center” custom_margin=”||-50px” custom_padding=”||10px|||”]

BRUCE VIELLE

CEO Groupe SYNERLAB 

[/et_pb_text][/et_pb_column][/et_pb_row][et_pb_row column_structure=”1_3,2_3″ _builder_version=”3.25.3″ background_size=”initial” background_position=”top_left” background_repeat=”repeat” width=”100%” custom_margin=”-400px||” custom_padding=”0px||”][et_pb_column type=”1_3″ _builder_version=”3.25″ custom_padding=”|||” custom_padding__hover=”|||”][et_pb_image src=”http://www.synerlab.com/wp-synerlab/wp-content/uploads/2019/07/20190122-SYNERLAB-Bruce-VIEILLE-0025-HD-e1561990329544.jpg” url_new_window=”on” align=”center” align_tablet=”center” align_phone=”” align_last_edited=”on|desktop” _builder_version=”3.25.3″ width=”81%” max_width=”82%” custom_margin=”150px|||” border_radii=”on|10px|10px|10px|10px” box_shadow_style=”preset2″ box_shadow_color=”rgba(17,5,1,0.38)”][/et_pb_image][/et_pb_column][et_pb_column type=”2_3″ _builder_version=”3.25″ custom_padding=”|||” custom_padding__hover=”|||”][et_pb_text admin_label=”Interview Piere Banzet” _builder_version=”3.27.4″ text_font=”Oxygen||||||||” text_text_color=”#000000″ text_font_size=”12px” text_line_height=”1.4em” header_2_font=”Oxygen||||||||” header_2_text_color=”#42bcff” header_2_font_size=”30px”]

 

 

Groupe SYNERLAB is taking on the objective to grow steadily in today’s challenging market, in order to assert its position as a leading European CDMO.

President Pierre Banzet has been striving to develop key solutions to provide our clients with best-in-class products and implemented actions to structure the Group around the six production sites in France and Spain in accordance with an operational excellence goal. These efforts paved the way for SYNERLAB’s future growth.

A new phase will start with a new management to further accelerate the Group’s development. Pierre Banzet will not have an executive role anymore but will keep on sharing his experience by joining the Supervisory Board.

As current General Manager of Groupe SYNERLAB and driven by my commitment to SYNERLAB’s values, Bruce will take on these responsibilities and will be appointed as the new CEO. He will strive to sustain the quality of products and services we have built over the last 45 years while improving the Group’s performance.

April 2019

[/et_pb_text][/et_pb_column][/et_pb_row][et_pb_row module_class=” et_pb_row_fullwidth” _builder_version=”3.25″ width=”89%” width_tablet=”80%” width_phone=”” width_last_edited=”on|desktop” max_width=”89%” max_width_tablet=”80%” max_width_phone=”” max_width_last_edited=”on|desktop” custom_margin=”||-80px” make_fullwidth=”on” locked=”off”][et_pb_column type=”4_4″ _builder_version=”3.25″ custom_padding=”|||” custom_padding__hover=”|||”][et_pb_divider _builder_version=”3.9″ custom_margin=”-60px|||” custom_padding=”50px||50px||true”][/et_pb_divider][/et_pb_column][/et_pb_row][/et_pb_section][et_pb_section fb_built=”1″ _builder_version=”3.22.3″ custom_margin=”-50px|||”][et_pb_row column_structure=”1_2,1_2″ _builder_version=”3.25″ background_size=”initial” background_position=”top_left” background_repeat=”repeat”][et_pb_column type=”1_2″ _builder_version=”3.25″ custom_padding=”|||” custom_padding__hover=”|||”][et_pb_image src=”http://www.synerlab.com/wp-synerlab/wp-content/uploads/2019/02/20160926-SYNERLAB-0024-e1550144331570.jpg” url=”https://pharmaboardroom.com/interviews/pierre-banzet-ceo-groupe-synerlab-france/” url_new_window=”on” align=”center” align_tablet=”center” align_phone=”” align_last_edited=”on|desktop” _builder_version=”3.23″ custom_margin=”20px|||” border_radii=”on|10px|10px|10px|10px” box_shadow_style=”preset2″ box_shadow_color=”rgba(17,5,1,0.38)”][/et_pb_image][/et_pb_column][et_pb_column type=”1_2″ _builder_version=”3.25″ custom_padding=”|||” custom_padding__hover=”|||”][et_pb_text admin_label=”Interview Piere Banzet” _builder_version=”3.27.4″ text_font=”Oxygen||||||||” text_text_color=”#000000″ text_font_size=”12px” text_line_height=”1.4em” header_2_font=”Oxygen||||||||” header_2_text_color=”#42bcff” header_2_font_size=”30px”]

 

Interview Pierre Banzet

CEO Groupe SYNERLAB

By Crystelle Coury, PharmaBoardroom –

(Feb. 2019)

Enjoy your reading!

[/et_pb_text][/et_pb_column][/et_pb_row][/et_pb_section][et_pb_section fb_built=”1″ _builder_version=”3.22.3″ custom_margin=”-50px|||”][et_pb_row module_class=” et_pb_row_fullwidth” _builder_version=”3.25″ width=”89%” width_tablet=”80%” width_phone=”” width_last_edited=”on|desktop” max_width=”89%” max_width_tablet=”80%” max_width_phone=”” max_width_last_edited=”on|desktop” custom_margin=”||-80px” make_fullwidth=”on”][et_pb_column type=”4_4″ _builder_version=”3.25″ custom_padding=”|||” custom_padding__hover=”|||”][et_pb_divider _builder_version=”3.9″ custom_margin=”-60px|||” custom_padding=”50px||50px||true”][/et_pb_divider][/et_pb_column][/et_pb_row][et_pb_row module_class=” et_pb_row_fullwidth” _builder_version=”3.25″ width=”89%” width_tablet=”80%” width_phone=”” width_last_edited=”on|desktop” max_width=”89%” max_width_tablet=”80%” max_width_phone=”” max_width_last_edited=”on|desktop” make_fullwidth=”on”][et_pb_column type=”4_4″ _builder_version=”3.25″ custom_padding=”|||” custom_padding__hover=”|||”][et_pb_text admin_label=”SERIALIZATION IS UP AND RUNNING!” _builder_version=”3.27.4″ text_font=”Oxygen||||||||” text_text_color=”#42bcff” header_2_font=”Oxygen||||||||” header_2_text_align=”center” header_2_text_color=”#42bcff” header_2_font_size=”35px” text_orientation=”center”]

SERIALIZATION IS UP AND RUNNING!

 

Enjoy your reading!

[/et_pb_text][et_pb_divider _builder_version=”3.9″ custom_margin=”-60px|||” custom_padding=”50px||50px||true”][/et_pb_divider][/et_pb_column][/et_pb_row][/et_pb_section][et_pb_section fb_built=”1″ _builder_version=”3.22.3″ custom_margin=”-50px|||”][et_pb_row module_class=” et_pb_row_fullwidth” _builder_version=”3.25″ width=”89%” width_tablet=”80%” width_phone=”” width_last_edited=”on|desktop” max_width=”89%” max_width_tablet=”80%” max_width_phone=”” max_width_last_edited=”on|desktop” make_fullwidth=”on”][et_pb_column type=”4_4″ _builder_version=”3.25″ custom_padding=”|||” custom_padding__hover=”|||”][et_pb_text admin_label=”LYOFAL given the go-ahead to produce cytotoxic medicinal products” _builder_version=”3.27.4″ text_font=”Oxygen||||||||” text_text_color=”#42bcff” header_2_font=”Oxygen||||||||” header_2_text_align=”center” header_2_text_color=”#42bcff” header_2_font_size=”35px” text_orientation=”center”]

LYOFAL  GIVEN THE GO-AHEAD TO PRODUCE CYTOTOXIC MEDICINAL PRODUCTS

 

Enjoy your reading!

[/et_pb_text][et_pb_divider _builder_version=”3.9″ custom_margin=”-60px|||” custom_padding=”50px||50px||true”][/et_pb_divider][/et_pb_column][/et_pb_row][/et_pb_section][et_pb_section fb_built=”1″ _builder_version=”3.22.3″ custom_margin=”-50px|||”][et_pb_row module_class=” et_pb_row_fullwidth” _builder_version=”3.25″ width=”89%” width_tablet=”80%” width_phone=”” width_last_edited=”on|desktop” max_width=”89%” max_width_tablet=”80%” max_width_phone=”” max_width_last_edited=”on|desktop” make_fullwidth=”on”][et_pb_column type=”4_4″ _builder_version=”3.25″ custom_padding=”|||” custom_padding__hover=”|||”][et_pb_text admin_label=”Communiqué Pierre Banzet” _builder_version=”3.27.4″ text_font=”Oxygen||||||||” text_text_color=”#42bcff” header_2_font=”Oxygen||||||||” header_2_text_align=”center” header_2_text_color=”#42bcff” header_2_font_size=”35px” text_orientation=”center” animation_style=”roll”]

 

GROUPE SYNERLAB WELCOMES A NEW

GENERAL MANAGER

 

 Enjoy your reading!

[/et_pb_text][et_pb_divider _builder_version=”3.9″ custom_margin=”-60px|||” custom_padding=”50px||50px||true”][/et_pb_divider][/et_pb_column][/et_pb_row][/et_pb_section][et_pb_section fb_built=”1″ _builder_version=”3.22.3″ custom_margin=”-50px|||”][et_pb_row module_class=” et_pb_row_fullwidth” _builder_version=”3.25″ width=”89%” width_tablet=”80%” width_phone=”” width_last_edited=”on|desktop” max_width=”89%” max_width_tablet=”80%” max_width_phone=”” max_width_last_edited=”on|desktop” make_fullwidth=”on”][et_pb_column type=”4_4″ _builder_version=”3.25″ custom_padding=”|||” custom_padding__hover=”|||”][et_pb_text admin_label=”Understanding the Challenges in designing & executing Clinical Trials for Screening Tests” _builder_version=”3.27.4″ text_font=”Oxygen||||||||” text_text_color=”#42bcff” header_2_font=”Oxygen||||||||” header_2_text_align=”center” header_2_text_color=”#42bcff” header_2_font_size=”35px” text_orientation=”center” animation_style=”zoom”]

UNDERSTANDING  THE CHALLENGES IN DESIGNING & EXECUTING CLINICAL TRIALS FOR SCREENING TESTS!

From Isabelle DECORTE, Head of Pharmaceutical Development & Operations, QP at Synerlab Développement, Orléans

 Enjoy your reading!

[/et_pb_text][et_pb_divider _builder_version=”3.9″ custom_margin=”-60px|||” custom_padding=”50px||50px||true”][/et_pb_divider][/et_pb_column][/et_pb_row][/et_pb_section][et_pb_section fb_built=”1″ _builder_version=”3.22.3″ custom_margin=”-50px|||”][et_pb_row module_class=” et_pb_row_fullwidth” _builder_version=”3.25″ width=”89%” width_tablet=”80%” width_phone=”” width_last_edited=”on|desktop” max_width=”89%” max_width_tablet=”80%” max_width_phone=”” max_width_last_edited=”on|desktop” make_fullwidth=”on”][et_pb_column type=”4_4″ _builder_version=”3.25″ custom_padding=”|||” custom_padding__hover=”|||”][et_pb_text admin_label=”SOFT GELATINS CAPSULS” _builder_version=”3.27.4″ text_font=”Oxygen||||||||” text_text_color=”#42bcff” header_2_font=”Oxygen||||||||” header_2_text_align=”center” header_2_text_color=”#42bcff” header_2_font_size=”35px” text_orientation=”center”]

WHAT IS ALCALA FARMA OFFERING FOR SOFT GELATIN CAPSULES?

 Enjoy your reading!

[/et_pb_text][et_pb_divider _builder_version=”3.9″ custom_margin=”-60px|||” custom_padding=”50px||50px||true”][/et_pb_divider][/et_pb_column][/et_pb_row][/et_pb_section][et_pb_section fb_built=”1″ _builder_version=”3.22.3″ custom_margin=”-50px|||”][et_pb_row module_class=” et_pb_row_fullwidth” _builder_version=”3.25″ width=”89%” width_tablet=”80%” width_phone=”” width_last_edited=”on|desktop” max_width=”89%” max_width_tablet=”80%” max_width_phone=”” max_width_last_edited=”on|desktop” make_fullwidth=”on”][et_pb_column type=”4_4″ _builder_version=”3.25″ custom_padding=”|||” custom_padding__hover=”|||”][et_pb_text admin_label=”Pansements lyophilises” _builder_version=”3.27.4″ text_font=”Oxygen||||||||” text_text_color=”#42bcff” header_2_font=”Oxygen||||||||” header_2_text_align=”center” header_2_text_color=”#42bcff” header_2_font_size=”35px” text_orientation=”center”]

INNOVATIVE LYOPHILIZED MEDICAL DEVICES

 Enjoy your reading!

[/et_pb_text][et_pb_divider _builder_version=”3.9″ custom_margin=”-80px|||” custom_padding=”50px||50px||true”][/et_pb_divider][/et_pb_column][/et_pb_row][/et_pb_section][et_pb_section fb_built=”1″ admin_label=”Image Dose” _builder_version=”3.22.3″ animation_style=”roll” border_radii=”on|20px|20px|20px|20px” border_style_all=”outset”][et_pb_row make_equal=”on” admin_label=”Image Doses 71″ _builder_version=”3.25″ background_size=”contain” width=”100%” max_width=”100%” module_alignment=”center” animation_style=”zoom” border_radii=”on|10px|10px|10px|10px” use_custom_width=”on” width_unit=”off” custom_width_percent=”100%”][et_pb_column type=”4_4″ _builder_version=”3.25″ custom_padding=”|||” custom_padding__hover=”|||”][et_pb_text _builder_version=”3.27.4″ header_font=”||||||||” header_2_font=”Oxygen||||||||” header_2_text_align=”center” header_2_text_color=”#42bcff” header_2_font_size=”35px” custom_margin=”|||”]

How to accelerate tablet formulation/process dvpt & secure scale up before industrial launch?

Good Reading!

[/et_pb_text][et_pb_divider _builder_version=”3.6″ custom_padding=”50px||50px||true” locked=”off”][/et_pb_divider][/et_pb_column][/et_pb_row][/et_pb_section][et_pb_section fb_built=”1″ _builder_version=”3.22.3″][et_pb_row module_class=” et_pb_row_fullwidth” _builder_version=”3.25″ width=”89%” width_tablet=”80%” width_phone=”” width_last_edited=”on|desktop” max_width=”89%” max_width_tablet=”80%” max_width_phone=”” max_width_last_edited=”on|desktop” make_fullwidth=”on”][et_pb_column type=”4_4″ _builder_version=”3.25″ custom_padding=”|||” custom_padding__hover=”|||”][et_pb_text admin_label=”Our new equipments titre” _builder_version=”3.27.4″ text_font=”Oxygen||||||||” text_text_color=”#42bcff” header_2_font=”Oxygen||||||||” header_2_text_align=”center” header_2_text_color=”#42bcff” header_2_font_size=”35px” text_orientation=”center”]

OUR NEW EQUIPMENTS

[/et_pb_text][et_pb_image src=”http://www.synerlab.com/wp-synerlab/wp-content/uploads/2018/06/New-RD-Equipments.jpg” url=”http://www.synerlab.com/wp-synerlab/wp-content/uploads/2018/06/New-RD-Equipments.jpg” url_new_window=”on” show_bottom_space=”off” align=”center” align_tablet=”center” align_phone=”” align_last_edited=”on|desktop” _builder_version=”3.23″ max_width=”65%” module_alignment=”center” animation_style=”bounce” animation_duration=”1200ms” border_radii=”on|10px|10px|10px|10px” box_shadow_style=”preset1″ box_shadow_horizontal=”18px” box_shadow_vertical=”18px” box_shadow_blur=”30px” box_shadow_spread=”17px”][/et_pb_image][et_pb_divider _builder_version=”3.6″ custom_padding=”50px||50px||true”][/et_pb_divider][/et_pb_column][/et_pb_row][/et_pb_section][et_pb_section fb_built=”1″ admin_label=”Image Dose” _builder_version=”3.22.3″ custom_margin=”-50px|||” animation_style=”roll” border_radii=”on|20px|20px|20px|20px” border_style_all=”outset”][et_pb_row make_equal=”on” admin_label=”Image Doses 71″ _builder_version=”3.25″ background_image=”http://www.synerlab.com/wp-synerlab/wp-content/uploads/2018/06/matrice_linkedin_doses_71.png” background_size=”contain” width=”100%” max_width=”100%” module_alignment=”center” custom_margin=”-100px|||” animation_style=”zoom” border_radii=”on|10px|10px|10px|10px” use_custom_width=”on” width_unit=”off” custom_width_percent=”100%”][et_pb_column type=”4_4″ _builder_version=”3.25″ custom_padding=”|||” custom_padding__hover=”|||”][et_pb_text _builder_version=”3.27.4″ header_font=”||||||||” header_2_font=”Oxygen||||||||” header_2_text_align=”center” header_2_text_color=”#42bcff” header_2_font_size=”35px” custom_margin=”50px|||”]

Great visibility of Groupe SYNERLAB in  DOSES 71  dd. May 2018.

Enjoy your reading!

[/et_pb_text][et_pb_divider show_divider=”off” _builder_version=”3.23.4″ height=”600px”][/et_pb_divider][/et_pb_column][/et_pb_row][/et_pb_section][et_pb_section fb_built=”1″ _builder_version=”3.22.3″][et_pb_row module_class=” et_pb_row_fullwidth” _builder_version=”3.25″ width=”89%” width_tablet=”80%” width_phone=”” width_last_edited=”on|desktop” max_width=”89%” max_width_tablet=”80%” max_width_phone=”” max_width_last_edited=”on|desktop” make_fullwidth=”on”][et_pb_column type=”4_4″ _builder_version=”3.25″ custom_padding=”|||” custom_padding__hover=”|||”][et_pb_text _builder_version=”3.27.4″ text_font=”Oxygen||||||||” text_text_color=”#42bcff” header_2_font=”Oxygen||||||||” header_2_text_align=”center” header_2_text_color=”#42bcff” header_2_font_size=”35px” text_orientation=”center”]

WE ARE SYNERLAB, NICE TO MEET YOU

Glad to let you know more about SYNERLAB

[/et_pb_text][/et_pb_column][/et_pb_row][/et_pb_section][et_pb_section fb_built=”1″ _builder_version=”3.22.3″ background_video_mp4=”http://www.synerlab.com/wp-synerlab/wp-content/uploads/2018/05/synerlab-infographie-anim.mp4″ max_width=”80%” max_width_tablet=”90%” max_width_phone=”” max_width_last_edited=”on|tablet” module_alignment=”center” border_radii=”on|10px|10px|10px|10px” box_shadow_style=”preset2″][et_pb_row _builder_version=”3.25″ module_alignment=”center” border_radii=”on|10px|10px|10px|10px”][et_pb_column type=”4_4″ _builder_version=”3.25″ custom_padding=”|||” custom_padding__hover=”|||”][et_pb_divider show_divider=”off” _builder_version=”3.23.4″ module_alignment=”center” height=”315px”][/et_pb_divider][/et_pb_column][/et_pb_row][/et_pb_section][et_pb_section fb_built=”1″ _builder_version=”3.22.3″ custom_margin=”30px|||”][et_pb_row module_class=” et_pb_row_fullwidth” _builder_version=”3.25″ width=”89%” width_tablet=”80%” width_phone=”” width_last_edited=”on|desktop” max_width=”89%” max_width_tablet=”80%” max_width_phone=”” max_width_last_edited=”on|desktop” make_fullwidth=”on”][et_pb_column type=”4_4″ _builder_version=”3.25″ custom_padding=”|||” custom_padding__hover=”|||”][et_pb_text _builder_version=”3.27.4″ text_font=”Oxygen||||||||” text_text_color=”#42bcff” header_2_font=”Oxygen||||||||” header_2_text_align=”center” header_2_text_color=”#42bcff” header_2_font_size=”35px” text_orientation=”center”]

SYNERLAB DÉVELOPPEMENT

INVESTMENTS FOR COMPLEX FORMULATIONS

[/et_pb_text][/et_pb_column][/et_pb_row][/et_pb_section][et_pb_section fb_built=”1″ specialty=”on” _builder_version=”3.22.3″ custom_margin=”-50px|||”][et_pb_column type=”1_2″ _builder_version=”3.25″ custom_padding=”|||” custom_padding__hover=”|||”][et_pb_image src=”http://www.synerlab.com/wp-synerlab/wp-content/uploads/2016/09/01825_patchwork.jpg” align_tablet=”center” align_phone=”” align_last_edited=”on|desktop” _builder_version=”3.23″ max_width=”80%” custom_margin=”|||20px” custom_padding=”|||20px” border_radii=”on|10px|10px|10px|10px” box_shadow_style=”preset2″][/et_pb_image][/et_pb_column][et_pb_column type=”1_2″ specialty_columns=”2″ _builder_version=”3.25″ custom_padding=”|||” custom_padding__hover=”|||”][et_pb_row_inner admin_label=”Ligne” _builder_version=”3.25″ custom_margin=”|||-20px” custom_padding=”|||0px”][et_pb_column_inner saved_specialty_column_type=”1_2″ _builder_version=”3.25″ custom_padding=”|||” custom_padding__hover=”|||”][et_pb_text _builder_version=”3.27.4″ text_font=”Oxygen||||||||” text_orientation=”justified” custom_margin=”10px|||”]

Specialized in pre-formulation to industrialization pharma development, Synerlab Développement develops oral solid forms by taking into account the regulatory, technical, therapeutic, commercial and insutrial exigencies. In order to adapt to the new formulation challenges posed by the higher number of increasingly complex molecular entities, Synerlab Développement has acquired hot extrusion equipment. This technology improves the bioavailability of active ingredients by adapting its release profile. For the purpose of developing with limited amounts of active ingredients drugs of major therapeutic interest that require quick clinical evaluation, the contract manufacturer has acquired a filling system that allows  the manufacture of low-close capsules of vials.

[/et_pb_text][/et_pb_column_inner][/et_pb_row_inner][/et_pb_column][/et_pb_section]